Glaukos Corporation (GKOS) is listed on NYSE in Medical Device Stocks. It is $179.79, -1.17%, with a $10.6B market cap. RSI is 57.4, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 57.4 Neutral
Market Cap $10.6B
Volume 379.3K
Fundamentals — 10-Q Q2 2026
Revenue $336.2M
Net Income $-38.2M
EPS $-0.65
Gross Margin 80.0%
Operating Margin -11.0%
Net Margin -11.4%
P/E Ratio -276.6x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Kliman Gilbert H | Insider | Sell | 2,500 | $190.00 | $475,000 | 2026 Aug 19 |
| Gilliam Joseph E | PRESIDENT & COO | Sell | 60,000 | $179.74 | $10.8M | 2026 Aug 11 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell | 20,000 | $180.13 | $3.6M | 2026 Aug 7 |
| Wen Leana | Insider | Sell | 525 | $167.63 | $88,006 | 2026 Jul 31 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell | 10,000 | $160.00 | $1.6M | 2026 Jul 16 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell | 10,000 | $155.00 | $1.6M | 2026 Jul 9 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell | 10,000 | $150.00 | $1.5M | 2026 Jul 6 |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Sell | 716 | $139.06 | $99,567 | 2026 Jul 1 |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Sell | 1,537 | $130.68 | $200,855 | 2026 Jun 16 |
| Kliman Gilbert H | Insider | Sell | 5,000 | $140.76 | $703,800 | 2026 May 14 |
| Kliman Gilbert H | Insider | Sell | 5,000 | $135.00 | $675,000 | 2026 May 11 |
| Gilliam Joseph E | PRESIDENT & COO | Sell | 19,573 | $143.54 | $2.8M | 2026 May 1 |
| Wen Leana | Insider | Sell | 1,700 | $143.35 | $243,695 | 2026 May 1 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell | 10,000 | $140.00 | $1.4M | 2026 Apr 30 |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Sell | 2,093 | $117.62 | $246,175 | 2026 Apr 10 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell | 2,511 | $106.46 | $267,321 | 2026 Mar 25 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell | 1,521 | $105.24 | $160,070 | 2026 Mar 24 |
| Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell | 625 | $99.15 | $61,969 | 2026 Mar 17 |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Sell | 1,031 | $98.04 | $101,078 | 2026 Mar 16 |
| Weisner Aimee S | Insider | Sell | 15,000 | $117.38 | $1.8M | 2026 Feb 19 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $71.19 | 38.1 | $13.9B |
| | $82.97 | 53.1 | $11.1B |
| | $26.13 | 58.4 | $13.5B |
| | $91.12 | 67.1 | $15.5B |
Take GKOS further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GKOS in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Glaukos Corporation next reports.
Set alerts on GKOS
Get notified when Glaukos Corporation hits your price targets or technical conditions are met.
Get Started Free